Cargando…
LGG-50. Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling
A major obstacle to identifying improved treatments for pediatric low-grade brain tumors (gliomas) is the inability to reproducibly generate human xenografts. To surmount this barrier, we leveraged human induced pluripotent stem cell (hiPSC) engineering to generate low-grade glioma (LGG) lesions rep...
Autores principales: | Anastasaki, Corina, Chatterjee, Jit, Cobb, Olivia, Scheaffer, Suzanne, Sanapala, Shilpa, Costa, Amanda, Wilson, Anna, Garbow, Joel, Rodriguez, Fausto, Gutmann, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164989/ http://dx.doi.org/10.1093/neuonc/noac079.362 |
Ejemplares similares
-
LGG-54. Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia
por: Chatterjee, Jit, et al.
Publicado: (2022) -
LGG-01. NF1 MUTATION DRIVES NEURONAL ACTIVITY-DEPENDENT OPTIC GLIOMA INITIATION
por: Pan, Yuan, et al.
Publicado: (2021) -
LGG-01. Children with Supratentorial Midline Pilocytic Astrocytomas Exhibit Multiple Progressions and Acquisition of Neurologic Deficits over Time
por: Brossier, Nicole, et al.
Publicado: (2022) -
LGG-11. Analysis of neurosurgical complications in pediatric supratentorial midline low-grade glioma – results from the German LGG studies
por: Weiß, Sarah, et al.
Publicado: (2022) -
LGG-11. INSTITUTIONAL EXPERIENCE OF BRAF TARGETING THERAPY
por: Lola, Gino Bardi, et al.
Publicado: (2020)